118 related articles for article (PubMed ID: 24715635)
1. Modifying the release properties of liposomes toward personalized medicine.
Cipolla D; Wu H; Gonda I; Eastman S; Redelmeier T; Chan HK
J Pharm Sci; 2014 Jun; 103(6):1851-62. PubMed ID: 24715635
[TBL] [Abstract][Full Text] [Related]
2. Aerosol performance and long-term stability of surfactant-associated liposomal ciprofloxacin formulations with modified encapsulation and release properties.
Cipolla D; Wu H; Gonda I; Chan HK
AAPS PharmSciTech; 2014 Oct; 15(5):1218-27. PubMed ID: 24889736
[TBL] [Abstract][Full Text] [Related]
3. Aerosol Performance and Stability of Liposomes Containing Ciprofloxacin Nanocrystals.
Cipolla D; Wu H; Gonda I; Chan HK
J Aerosol Med Pulm Drug Deliv; 2015 Dec; 28(6):411-22. PubMed ID: 26469306
[TBL] [Abstract][Full Text] [Related]
4. Tuning Ciprofloxacin Release Profiles from Liposomally Encapsulated Nanocrystalline Drug.
Cipolla D; Wu H; Eastman S; Redelmeier T; Gonda I; Chan HK
Pharm Res; 2016 Nov; 33(11):2748-62. PubMed ID: 27439506
[TBL] [Abstract][Full Text] [Related]
5. In vitro and ex vivo methods predict the enhanced lung residence time of liposomal ciprofloxacin formulations for nebulisation.
Ong HX; Benaouda F; Traini D; Cipolla D; Gonda I; Bebawy M; Forbes B; Young PM
Eur J Pharm Biopharm; 2014 Jan; 86(1):83-9. PubMed ID: 23851077
[TBL] [Abstract][Full Text] [Related]
6. Effect of preparation technique on the properties of liposomes encapsulating ketoprofen-cyclodextrin complexes aimed for transdermal delivery.
Maestrelli F; González-Rodríguez ML; Rabasco AM; Mura P
Int J Pharm; 2006 Apr; 312(1-2):53-60. PubMed ID: 16469460
[TBL] [Abstract][Full Text] [Related]
7. Ocular ciprofloxacin hydrochloride mucoadhesive chitosan-coated liposomes.
Abdelbary G
Pharm Dev Technol; 2011 Feb; 16(1):44-56. PubMed ID: 20025433
[TBL] [Abstract][Full Text] [Related]
8. Successful co-encapsulation of benzoyl peroxide and chloramphenicol in liposomes by a novel manufacturing method - dual asymmetric centrifugation.
Ingebrigtsen SG; Škalko-Basnet N; de Albuquerque Cavalcanti Jacobsen C; Holsæter AM
Eur J Pharm Sci; 2017 Jan; 97():192-199. PubMed ID: 27866016
[TBL] [Abstract][Full Text] [Related]
9. Exposure of liposomes containing nanocrystallised ciprofloxacin to digestive media induces solid-state transformation and altered in vitro drug release.
Li T; Hawley A; Rades T; Boyd BJ
J Control Release; 2020 Jul; 323():350-360. PubMed ID: 32335156
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of temoporfin-loaded liposome formulations: correlation of liposome and temoporfin blood concentration.
Decker C; Schubert H; May S; Fahr A
J Control Release; 2013 Mar; 166(3):277-85. PubMed ID: 23313962
[TBL] [Abstract][Full Text] [Related]
11. Solid State Characterization of Ciprofloxacin Liposome Nanocrystals.
Li T; Mudie S; Cipolla D; Rades T; Boyd BJ
Mol Pharm; 2019 Jan; 16(1):184-194. PubMed ID: 30495965
[TBL] [Abstract][Full Text] [Related]
12. In-vitro and in-vivo evaluation of ciprofloxacin liposomes for pulmonary administration.
Liu C; Shi J; Dai Q; Yin X; Zhang X; Zheng A
Drug Dev Ind Pharm; 2015 Feb; 41(2):272-8. PubMed ID: 24252110
[TBL] [Abstract][Full Text] [Related]
13. Tamoxifen in topical liposomes: development, characterization and in-vitro evaluation.
Bhatia A; Kumar R; Katare OP
J Pharm Pharm Sci; 2004 Jul; 7(2):252-9. PubMed ID: 15367383
[TBL] [Abstract][Full Text] [Related]
14. Spray-freeze-dried liposomal ciprofloxacin powder for inhaled aerosol drug delivery.
Sweeney LG; Wang Z; Loebenberg R; Wong JP; Lange CF; Finlay WH
Int J Pharm; 2005 Nov; 305(1-2):180-5. PubMed ID: 16242277
[TBL] [Abstract][Full Text] [Related]
15. Development of vitamin loaded topical liposomal formulation using factorial design approach: drug deposition and stability.
Padamwar MN; Pokharkar VB
Int J Pharm; 2006 Aug; 320(1-2):37-44. PubMed ID: 16707237
[TBL] [Abstract][Full Text] [Related]
16. Formation of drug-arylsulfonate complexes inside liposomes: a novel approach to improve drug retention.
Zhigaltsev IV; Maurer N; Edwards K; Karlsson G; Cullis PR
J Control Release; 2006 Jan; 110(2):378-386. PubMed ID: 16318894
[TBL] [Abstract][Full Text] [Related]
17. Microfluidics assembly of inhalable liposomal ciprofloxacin characterised by an innovative in vitro pulmonary model.
Zhang Y; Wong CYJ; Gholizadeh H; Aluigi A; Tiboni M; Casettari L; Young P; Traini D; Li M; Cheng S; Ong HX
Int J Pharm; 2023 Mar; 635():122667. PubMed ID: 36738806
[TBL] [Abstract][Full Text] [Related]
18. The liposomal formulation of doxorubicin.
Abraham SA; Waterhouse DN; Mayer LD; Cullis PR; Madden TD; Bally MB
Methods Enzymol; 2005; 391():71-97. PubMed ID: 15721375
[TBL] [Abstract][Full Text] [Related]
19. Treatment of experimental osteomyelitis by liposomal antibiotics.
Kadry AA; Al-Suwayeh SA; Abd-Allah AR; Bayomi MA
J Antimicrob Chemother; 2004 Dec; 54(6):1103-8. PubMed ID: 15486079
[TBL] [Abstract][Full Text] [Related]
20. Use of a passive equilibration methodology to encapsulate cisplatin into preformed thermosensitive liposomes.
Woo J; Chiu GN; Karlsson G; Wasan E; Ickenstein L; Edwards K; Bally MB
Int J Pharm; 2008 Feb; 349(1-2):38-46. PubMed ID: 17728083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
